Pronova BIOPHARMA

You are here: Home / Investors / Reports and presentations

Quarterly presentations

Last ned fil

Presentation Q1 10

Last ned fil

PresentationQ42009-1.pdf

Last ned fil

Presentation Q3 09

Last ned fil

Presentation Q2 09

Last ned fil

Presentation Q1 09

Last ned fil

Presentation Q3 08

Last ned fil

Presentation Q2 08

Last ned fil

Presentation Q1 08

Last ned fil

Presentation Q4 07

Last ned fil

Presentation Q3 07

Quarterly reports

Last ned fil

Report Q1 10

Last ned fil

Report Q4 09

Last ned fil

Report Q3 09

Last ned fil

Report Q2 09

Last ned fil

Report Q1 09

Last ned fil

Report Q4 08

Last ned fil

Report Q3 08

Last ned fil

Report Q2 08

Last ned fil

Report Q1 08

Last ned fil

Report Q4 07

Last ned fil

Report Q3 07

Spread sheets

Last ned fil

Key figures by quarter;2007 - Q4 2009.xls

Annual reports

Last ned fil

Annual report 2009

Last ned fil

Annual report 2008

Last ned fil

Annual report 2007

Webcast presentations

Webcast Q2 - 09

Webcast Q1 - 09

Webcast Q4 - 08

Webcast Q3 - 08

Capital markets day 2009

Last ned fil

1 Introduction

Last ned fil

2 ORIGIN

Last ned fil

3 Manufacturing

Last ned fil

4 Commercial update

Last ned fil

5 IMS

Last ned fil

6a R&D and clinical

Last ned fil

6b R&D and clinical

Other presentations

Last ned fil

Presentation at Carnegie's Nordic healthcare seminar March 2010

Last ned fil

Presentation at Aksjedagen Norge, November 2009

Last ned fil

Presentation for UBS September 2009

Last ned fil

Odin Presentation March 2009

Last ned fil

Company presentation March 2009

Last ned fil

Presentation for UBS September 2008,New York

Last ned fil

Presentation for DnB NOR markets & Carnegie September 2008

Last ned fil

Investor presentation 2007

Last ned fil

Roadshow presentation 2007

Prospectuses

Last ned fil

Offer prospectus 10 October 2007.pdf

Capital markets day 2008

Last ned fil

1 Programme

Last ned fil

2 Markets & partners

Last ned fil

3a Manufacturing

Last ned fil

3b Manufacturing new site

Last ned fil

4 R&D and medical affairs

Last ned fil

5 Medical affairs

Last ned fil

6 The GISSI-HF study

Last ned fil

7 R&D strategy

Last ned fil

8 Atrial fibrillation present and future

Last ned fil

9 Omacor/Lovaza franchise potential

Copyright 2007 © Pronova BioPharma ASA

Idium web publishing

idium web publishing